The potent immunomodulatory functions of VIP have been demonstrated both in vivo, in a murine model of collagen-induced arthritis [10], and ex vivo, in cultured fibroblast-like synoviocytes and in peripheral blood lymphocytes of patients with rheumatoid arthritis [10, 11]. The gene discussed is VIP; the disease is rheumatoid arthritis.